Urokinase combination chemotherapy in sm
β
F. A. Calvo; O. F. Hidalgo; F. Gonzalez; J. Rebollo; S. Martin Algarra; D. Ortiz
π
Article
π
1992
π
John Wiley and Sons
π
English
β 770 KB
## Background and methods: Fifty-one patients with small cell lung cancer (sclc) were treated with alternating urokinase (uk)-cyclophosphamide-doxorubicin (adriamycin, adria laboratories, columbus, oh)-vincristine and cisplatin-etoposide-vincristine. uk was given as a loading dose of 3000 microgram